(Q39655391)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

main subject

hepatocellular carcinoma

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Antonio Mazzocca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Amalia Azzariti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Emilia Fransvea

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Angela Santamato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Salvatore Antonaci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

16 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

79-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20844878%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00280-010-1459-x

14 February 2020

exact match

0 references

cites work

Hepatocellular carcinoma: recent trends in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Protein microarrays: meeting analytical challenges for clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Essential role of TGF-beta signaling in glucose-induced cell hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X

Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1459-X